Maternus-Kliniken Aktiengesellschaft (MAK.DE)
EUR 1.49
(-2.61%)
EUR 1.49
(-2.61%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 11.9 Million EUR | -97.52% |
| 2022 | 86.97 Million EUR | -10.81% |
| 2021 | 97.51 Million EUR | -0.19% |
| 2020 | 97.69 Million EUR | -5.02% |
| 2019 | 102.86 Million EUR | 0.01% |
| 2018 | 102.85 Million EUR | -2.39% |
| 2017 | 105.37 Million EUR | 2.28% |
| 2016 | 103.03 Million EUR | 0.5% |
| 2015 | 102.51 Million EUR | 2.55% |
| 2014 | 99.96 Million EUR | 7.27% |
| 2013 | 93.18 Million EUR | -3.01% |
| 2012 | 96.07 Million EUR | 5.34% |
| 2011 | 91.2 Million EUR | -0.22% |
| 2010 | 91.4 Million EUR | -0.02% |
| 2009 | 91.42 Million EUR | 3.94% |
| 2008 | 87.96 Million EUR | 2.62% |
| 2007 | 85.72 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 7.66 Million EUR | 0.0% |
| 2023 Q3 | 2.89 Million EUR | -87.56% |
| 2023 Q4 | 2.89 Million EUR | 0.0% |
| 2023 FY | 2.15 Million EUR | -97.52% |
| 2023 Q1 | 3.05 Million EUR | 7178.57% |
| 2023 Q2 | 23.27 Million EUR | 661.24% |
| 2022 FY | 86.97 Million EUR | -10.81% |
| 2022 Q2 | 22.89 Million EUR | 323.24% |
| 2022 Q3 | 2.8 Million EUR | -87.74% |
| 2022 Q1 | 5.4 Million EUR | -36.84% |
| 2022 Q4 | 42 Thousand EUR | -98.5% |
| 2021 Q1 | 7.38 Million EUR | -20.02% |
| 2021 Q3 | 7 Million EUR | -71.85% |
| 2021 Q2 | 24.89 Million EUR | 237.18% |
| 2021 Q4 | 8.56 Million EUR | 22.23% |
| 2021 FY | 97.51 Million EUR | -0.19% |
| 2020 Q1 | 6.24 Million EUR | -5.77% |
| 2020 Q2 | 23.34 Million EUR | 273.89% |
| 2020 FY | 97.69 Million EUR | -5.02% |
| 2020 Q3 | 7.51 Million EUR | -67.82% |
| 2020 Q4 | 9.23 Million EUR | 22.87% |
| 2019 Q3 | 6.29 Million EUR | -75.78% |
| 2019 Q2 | 25.98 Million EUR | 318.18% |
| 2019 Q1 | 6.21 Million EUR | 8.69% |
| 2019 FY | 102.86 Million EUR | 0.01% |
| 2019 Q4 | 6.62 Million EUR | 5.27% |
| 2018 Q4 | 5.71 Million EUR | 0.0% |
| 2018 Q2 | 25.75 Million EUR | 243.07% |
| 2018 FY | 102.85 Million EUR | -2.39% |
| 2018 Q1 | 7.5 Million EUR | -8.28% |
| 2018 Q3 | 5.71 Million EUR | -77.8% |
| 2017 Q2 | 26.01 Million EUR | 222.82% |
| 2017 Q3 | 8.18 Million EUR | -68.54% |
| 2017 Q4 | 8.18 Million EUR | 0.0% |
| 2017 Q1 | 8.05 Million EUR | -2.38% |
| 2017 FY | 105.37 Million EUR | 2.28% |
| 2016 Q4 | 8.25 Million EUR | 0.0% |
| 2016 FY | 103.03 Million EUR | 0.5% |
| 2016 Q2 | 25.49 Million EUR | 218.16% |
| 2016 Q3 | 8.25 Million EUR | -67.63% |
| 2016 Q1 | 8.01 Million EUR | -68.15% |
| 2015 Q4 | 25.16 Million EUR | -3.16% |
| 2015 FY | 102.51 Million EUR | 2.55% |
| 2015 Q3 | 25.98 Million EUR | 0.29% |
| 2015 Q2 | 25.9 Million EUR | 1.78% |
| 2015 Q1 | 25.45 Million EUR | 0.7% |
| 2014 Q4 | 25.28 Million EUR | -3.0% |
| 2014 Q3 | 26.06 Million EUR | 4.85% |
| 2014 Q2 | 24.85 Million EUR | 4.5% |
| 2014 Q1 | 23.78 Million EUR | 6.74% |
| 2014 FY | 99.96 Million EUR | 7.27% |
| 2013 Q4 | 22.28 Million EUR | -8.68% |
| 2013 Q3 | 24.4 Million EUR | 3.21% |
| 2013 Q2 | 23.64 Million EUR | 3.45% |
| 2013 Q1 | 22.85 Million EUR | -3.2% |
| 2013 FY | 93.18 Million EUR | -3.01% |
| 2012 Q1 | 22.96 Million EUR | 0.54% |
| 2012 Q2 | 24.21 Million EUR | 5.45% |
| 2012 Q3 | 25.28 Million EUR | 4.4% |
| 2012 FY | 96.07 Million EUR | 5.34% |
| 2012 Q4 | 23.61 Million EUR | -6.62% |
| 2011 Q4 | 22.84 Million EUR | -1.71% |
| 2011 Q3 | 23.24 Million EUR | 1.48% |
| 2011 Q2 | 22.9 Million EUR | 3.06% |
| 2011 FY | 91.2 Million EUR | -0.22% |
| 2011 Q1 | 22.22 Million EUR | -0.19% |
| 2010 FY | 91.4 Million EUR | -0.02% |
| 2010 Q4 | 22.26 Million EUR | -6.75% |
| 2010 Q3 | 23.87 Million EUR | 2.41% |
| 2010 Q2 | 23.31 Million EUR | 6.16% |
| 2010 Q1 | 21.96 Million EUR | 0.0% |
| 2009 FY | 91.42 Million EUR | 3.94% |
| 2008 FY | 87.96 Million EUR | 2.62% |
| 2007 FY | 85.72 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 4.92 Billion EUR | 99.758% |
| Fresenius SE & Co. KGaA | 5.05 Billion EUR | 99.765% |
| LIMES Schlosskliniken AG | 13.58 Million EUR | 12.39% |
| M1 Kliniken AG | 26.66 Million EUR | 55.361% |
| MEDICLIN Aktiengesellschaft | 144.11 Million EUR | 91.741% |
| RHÖN-KLINIKUM Aktiengesellschaft | 198.49 Million EUR | 94.004% |
| VITA 34 AG | 28.24 Million EUR | 57.86% |